An Integrated Computational/Experimental Model of Lymphoma Growth

PLoS Computational Biology

Volumn 9, Issue 3, 2013, Pages

  Frieboes, Hermann B ^a,b,c   Smith, Bryan R ^d   Chuang, Yao Li ^c   Ito, Ken ^d   Roettgers, Allison M ^a   Gambhir, Sanjiv S ^d,e   Cristini, Vittorio ^c,f  

^a University of Louisville   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Stanford University   (United States)

^f MSC01 1070   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPUTATION THEORY; CYTOLOGY; DRUG THERAPY; ONCOLOGY;

COMPUTATIONAL MODELLING; CRITICAL ELEMENTS; EXPERIMENTAL MODELLING; IN-VIVO; LYMPHOMA CELLS; MALIGNANT CANCERS; NON-HODGKIN LYMPHOMA; PHYSICAL DYNAMICS; TUMOR GROWTH; TUMOUR SUPPRESSOR;

TUMORS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER RESISTANCE; CELL TRANSPORT; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INGUINAL LYMPH NODE; INTERMETHOD COMPARISON; LYMPHOMA CELL; MATHEMATICAL MODEL; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PHENOTYPE; PREDICTION; SPATIOTEMPORAL ANALYSIS;

EID: 84876005514     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003008     Document Type: Article

References (67)

1. Mahadevan D, Fisher RI, (2011) Novel therapeutics for aggressive non-Hodgkin's lymphoma. J Clin Oncol 29: 1876-1884.
2. Lowengrub JS, Frieboes HB, Jin F, Chuang YL, Li X, et al. (2010) Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23: R1-R9.
3. Frieboes HB, Chaplain MA, Thompson AM, Bearer EL, Lowengrub JS, et al. (2011) Physical oncology: a bench-to-bedside quantitative and predictive approach. Cancer Res 71: 298-302.
4. Byrne HM, (2010) Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 10: 221-230.
5. Astanin S, Preziosi L (2007) Multiphase Models of Tumour Growth. In: Bellomo N, Chaplain M, DeAngelis E, editors. Selected Topics on Cancer Modelling: Genesis- Evolution- Immune Competition - Therapy. Boston: Birkhäuser. pp. 1-31.
6. Harpold HL, Alvord Jr. EC, Swanson KR, (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66: 1-9.
7. Anderson ARA, Quaranta V, (2008) Integrative mathematical oncology. Nat Rev Cancer 8: 227-244.
8. Deisboeck TS, Zhang L, Yoon J, Costa J, (2009) In silico cancer modeling: is it ready for prime time? Nature Clin Practice Oncol 6: 34-42.
9. Ventura AC, Jackson TL, Merajver SD, (2009) On the role of cell signaling models in cancer research. Cancer Res 69: 400-402.
10. Quaranta V, Weaver AM, Cummings PT, Anderson ARA, (2005) Mathematical modeling of cancer: the future of prognosis and treatment. Clin Chim Acta 357: 173-179.
11. Nagy JD, (2005) The ecology and evolutionary biology of cancer: A review of mathematical models of necrosis and tumor cell diversity. Math Biosci Eng 2: 381-418.
12. Abbott RG, Forrest S, Pienta KJ, (2006) Simulating the hallmarks of cancer. Art Life 12: 617-34.
13. Byrne HM, Alarcón T, Owen MR, Webb SW, Maini PK, (2006) Modeling aspects of cancer dynamics: A review. Phi Trans R Soc A 364: 1563-1578.
14. Fasano A, Bertuzzi A, Gandolfi A (2006) Mathematical modelling of tumour growth and treatment. In: Complex Systems in Biomedicine. Milan: Springer. Pp. 71-108.
15. Galle J, Aust G, Schaller G, Beyer T, Drasdo D, (2006) Individual cell-based models of the spatial temporal organization of multicellular systems-achievements and limitations. Cytometry A 69: 704-710.
16. Drasdo D, Höhme S, (2007) On the role of physics in the growth and pattern of multicellular systems: What we learn from individual-cell based models? J Stat Phys 128: 287-345.
17. Thorne BC, Bailey AM, Peirce SM, (2007) Combining experiments with multi-cell agent-based modeling to study biological tissue patterning. Briefings Bioinformatics 8: 245-257.
18. Anderson ARA, Chaplain M, Rejniak K, Fozard J, (2008) Single-cell based models in biology and medicine. Math Med Biol 25: 185-186.
19. Quaranta V, Rejniak K, Gerlee P, Anderson ARA, (2008) Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. Sem Cancer Biol 18: 338-348.
20. Zhang L, Wang Z, Sagotsky JA, Deisboeck TS, (2009) Multiscale agent-based cancer modeling. J Math Biol 58: 545-559.
21. Kim Y, Stolarska MA, Othmer HG, (2007) A hybrid model for tumor spheroid growth in vitro: I. Theoretical development and early results. Math Methods Appl Sci 17: 1773-1798.
22. Stolarska MA, Kim Y, Othmer HG, (2009) Multiscale models of cell and tissue dynamics. Phil Trans R Soc A 367: 3525-3553.
23. Bearer EL, Lowengrub JS, Frieboes HB, Chuang YL, Jin F, et al. (2009) Multiparameter computational modeling of tumor invasion. Cancer Res 69: 4493-4501.
24. Ribba B, Marron K, Agur Z, Alarcón T, Maini PK, (2005) A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results. Bull Math Biol 67: 79-99.
25. Alarcón T, Marches R, Page KM, (2006) Mathematical models of the fate of lymphoma B cells after antigen receptor ligation with specific antibodies. J Theor Biol 240: 54-71.
26. Meyer-Hermann ME, (2007) Are T cells at the origin of B cell lymphomas? J Theor Biol 244: 656-669.
27. Evens AM, Schumacker PT, Helenowski IB, Singh AT, Dokic D, et al. (2008) Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family. Br J Haematol 141: 676-680.
28. Frieboes HB, Edgerton ME, Fruehauf JP, Rose FR, Worrall LK, et al. (2009) Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res 69: 4484-4492.
29. Sinek JP, Sanga S, Zheng X, Frieboes HB, Ferrari M, et al. (2009) Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol 58: 485-510.
30. Frieboes HB, Lowengrub JS, Wise S, Zheng X, Macklin P, et al. (2007) Computer simulation of glioma growth and morphology. NeuroImage 37 (Suppl 1):: S59-70.
31. Wise SM, Lowengrub J, Frieboes HB, Cristini V, (2008) Three-dimensional multispecies nonlinear tumor growth-I Model and numerical method. J Theor Biol 253: 524-543.
32. Frieboes HB, Jin F, Chuang YL, Wise SM, Lowengrub JS, et al. (2010) Three-dimensional multispecies tumor growth-II: Tumor invasion and angiogenesis. J Theor Biol 264: 1254-1278.
33. Chauviére AH, Hatzikirou H, Lowengrub JS, Frieboes HB, Thompson AM, et al. (2010) Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer? Curr Breast Cancer Rep 2: 121-129.
34. Deisboeck TS, Wang Z, Macklin P, Cristini V, (2011) Multiscale cancer modeling. Annu Rev Biomed Eng 13: 127-155.
35. Hatzikirou H, Chauviere A, Bauer AL, Leier A, Lewis MT, et al. (2012) Integrative physical oncology. Wiley Interdiscip Rev Syst Biol Med 4: 1-14.
36. Edgerton M, Chuang Y, Macklin P, Yang W, Bearer EL, et al. (2011) A Novel, Patient-Specific Mathematical Pathology Approach For Assessment Of Surgical Volume: Application To Ductal Carcinoma In Situ Of The Breast. Anal Cell Pathol 34: 1-17.
37. Macklin P, Edgerton ME, Thompson AM, Cristini V, (2012) Patient-calibrated agent-based modeling of ductal carcinoma in situ (DCIS): From microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 301: 122-140.
38. Morin PJ, (2003) Drug resistance and the microenvironment: nature and nurture. Drug Resist Updates 6: 169-172.
39. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, et al. (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
40. Lowe SW, Sherr CJ, (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13: 77-83.
41. Tomida A, Tsuruo T, (1999) Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anti-Cancer Drug Design 14: 169-177.
42. Sobocinski GP, Toy K, Bobrowski WF, Shaw S, Anderson AO, et al. (2010) Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: evidence supporting the reticular network as a pathway for lymphocyte migration. BMC Immunology 11: 42.
43. Ma B, Jablonska J, Lindenmaier W, Dittmar KEJ, (2007) Immunohistochemical study of the reticular and vascular network of mouse lymph node using vibratome sections. Acta Histochemica 109: 15-28.
44. Koster A, Raemaekers JM, (2005) Angiogenesis in malignant lymphoma. Curr Opin Oncol 17: 611-616.
45. Ruan J, Hajjar K, Rafii S, Leonard JP, (2009) Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma. Annals of Oncology 20: 413-424.
46. Anderson AR, Chaplain MA, (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 60: 857-899.
47. Plank MJ, Sleeman BD, (2003) A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. Math Med Biol 20: 135-181.
48. Plank MJ, Sleeman BD, (2004) Lattice and non-lattice models of tumour angiogenesis. Bull Math Biol 66: 1785-1819.
49. Nugent LJ, Jain RK, (1984) Extravascular diffusion in normal and neoplastic tissues. Cancer Res 44: 238-244.
50. Sherratt JA, Murray JD, (1990) Models of epidermal wound healing. Proc Roy Soc Lond B241: 29-36.
51. Cristini V, Lowengrub J, Nie Q, (2003) Nonlinear simulation of tumor growth. J Math Biol 46: 191-224.
52. Li X, Lowengub J, Rätz A, Voigt A, (2009) Solving PDEs in complex geometries: a diffuse domain approach. Commun Math Sci 7: 81-107.
53. Ito K, Smith BR, Parashurama N, Yoon J-K, Song SY, et al. (2012) Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node. Cancer Res 72: 6111-6118.
54. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, et al. (2006) An Integrated Computational/Experimental Model of Tumor Invasion. Cancer Res 66: 1597-1604.
55. Li X, Cristini V, Nie Q, Lowengrub J, (2007) Nonlinear three-dimensional simulation of solid tumor growth. Discrete Cont Dyn Sys B 7: 581-604.
56. Cristini V, Lowengrub JS, (2010) Multiscale Modeling of Cancer: An Integrated Experimental and Mathematical Modeling Approach. Cambridge University Press.
57. Grantab R, Sivananthan S, Tannock IF, (2006) The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 66: 1033-1039.
58. Drillenburg P, Pals ST, (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95: 1900-1910.
59. Muniz VP, Barnes JM, Paliwal S, Zhang X, Tan X, et al. (2011) The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis. Mol Cancer Res 9: 867-877.
60. Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, et al. (2006) Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol 26: 2360-2372.
61. Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, et al. (2007) The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res 67: 9322-9329.
62. Chen YW, Paliwal S, Draheim K, Grossman SR, Lewis BC, (2008) p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res 68: 476-482.
63. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, et al. (1997) Proliferation of adult T cell leukemiaylymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 94: 13897-13902.
64. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91.
65. Semenza GL, (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103.
66. Freitas AA, Rocha B, Coutinho AA, (1986) Life span of B lymphocytes: the experimental basis for conflicting results. J Immunol 136: 470-476.
67. Young AJ, Hay JB, Miyasaka M, (1995) Rapid turnover of the recirculating lymphocyte pool in vivo. Int Immunol 7: 1607-1615.